Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H
-
EcoFlow Unveils Next-Gen Power Solutions for Every Lifestyle -- from the Home to the Outdoors to Life On The Go
-
VYNE Therapeutics to Participate in September Investor Conferences
-
Elysium Therapeutics Presents Phase 1 Proof-of-Concept Results for Novel SMART™ O2P Opioid Technology for Acute Pain that Reduces the Potential for Abuse, Diversion, and Risk of Oral Overdose at PAI
-
TeleSafety Launches Groundbreaking AI Platform That Provides Instant Answers to OSHA Questions and Builds Safety Programs for Clients in Real-time
-
Earnix and Hexaware Partner to Accelerate Insurance Pricing Transformation
-
SPEYSIDE COMPLETES CARVEOUT OF REED MINERALS
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
-
Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML
-
Cheche Group Announces Partnership with NEV Company JI YUE
-
RedDress Announces Randomized Controlled Trial Results Showing Significant Benefits of ActiGraft Pro for Diabetic Foot Ulcers
-
NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024
-
PharmaCann Kicks Off 3rd Quarter with Star-Studded Film Premiere and Exciting New Product Launches in New York State
-
PriceSmart Announces Earnings Release and Conference Call Details for the Fourth Quarter of Fiscal 2024
-
Makers of HORMEL® BLACK LABEL® Bacon Launch First-Ever Co-Branded Bacon with CINNAMON TOAST CRUNCH™
-
Lowe's Returns as Official Home Improvement Partner of NFL for 2024-25 Season
-
Generative AI market to reach US$1.5 trillion by 2030 with Taiwan holds hardware advantage; software and services to see promising future, says DIGITIMES Research
-
Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Leidos awarded CDC's National Health Safety Network modernization contract
-
Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extend
-
Vasa Therapeutics Announces Initiation of Phase 1 First-in-Human Clinical Trial of VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction
-
Rectify Pharmaceuticals Appoints Pol Boudes as Chief Medical Officer
-
Enviri Corporation to participate in upcoming investor conferences
-
NexTech Solutions (NTS) Acquires Virginia-Based IT Company Nomad Solutions, Expanding Support to Federal Civilian Executive Agencies
-
PANTHERx® Rare Selected by Calliditas Therapeutics as Specialty Pharmacy for TARPEYO®
-
The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference
-
University of Mississippi Medical Center Launches Student Loan Benefit with Fiducius to Support Employee Recruiting and Retentions Efforts
-
Pole Star Global Expands Maritime Intelligence with Launch of the DOMAIN Insights Engine Plus New Global Brand
-
LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
Maxeon Solar Technologies Announces Second Quarter 2024 Financial Results
-
FIT KING's Award-Winning Innovation: The Recovery Pro Full Leg Compression Massage Boots
-
First Federal Savings Bank and ICBA: Take Steps to Safeguard Your Finances During National Preparedness Month
-
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
-
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
-
Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions
-
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
Easterly Government Properties Completes Acquisition of VA - Jacksonville, the Final Acquisition of the 10 Properties in the VA Portfolio
-
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Hedge Fund Association Announces Results of 2024 Global Board of Directors Election
-
Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
-
Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for Zorevunersen to be the First Disease-Modifying Medicine for the Treatment of Dravet
-
ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)
-
Golden State Wealth Management Welcomes New Advisor, Valerie Krebs
-
SENKO AND US CONEC SETTLE VSFF CONNECTOR AND ADAPTER PATENT DISPUTES
-
Cogent Biosciences Announces Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST) Has Completed Enrollment and Advanced Past Interim Futility Analysis
-
Applebee’s® Kicks Off the 2024 NFL Season with America’s Favorite Boneless Wings for Only 50 Cents
-
IntegriChain Appoints Tim Murdoch as Chief Commercial Officer to Drive Continued Growth and Customer Value
-
Calamos Announces Launch and Upside Cap Rates for CPST and CPNS: Structured Protection ETFs Providing Exposure to S&P 500 and Nasdaq-100 with 100% Downside Protection Over One Year
-
The US Oncology Network Extends its Reach in Illinois as Illinois CancerCare Joins The Network
-
Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer
